Emerging treatment options for ovarian cancer: focus on rucaparib
Lavanya Mariappan,1 Xue Yan Jiang,1 Josie Jackson,2 Yvette Drew2 1Northern Centre for Cancer Care, Freeman Hospital, 2Northern Institute for Cancer Research, Newcastle University, Newcastle-upon-Tyne, UK Abstract: Poly(ADP-ribose) polymerase (PARP) inhibitors (PARPi) are an exciting class of antic...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-12-01
|
Series: | International Journal of Women's Health |
Subjects: | |
Online Access: | https://www.dovepress.com/emerging-treatment-options-for-ovarian-cancer-focus-on-rucaparib-peer-reviewed-article-IJWH |